Data / Drug companies / Tapi Hungary Industries Kft.
Tapi Hungary Industries Kft.: 21 products in the FDA NDC directory, labeler code 84671
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Tapi Hungary Industries Kft. (labeler code 84671) lists 21 products in the FDA National Drug Code Directory. By type: 21 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on June 12, 2026.
The request: Watch Tapi Hungary Industries Kft. (FDA labeler code 84671): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 84671
- Products in commercial distribution
- 21
- Packages
- 21
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule II 1, Schedule IV 1
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- November 8, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 21 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 21 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 21 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Oripavine | 84671-1062 | Powder | Bulk ingredients | June 12, 2026 |
| Fidaxomicin | 84671-1054 | Powder | Bulk ingredients | August 11, 2025 |
| Pacritinib citrate | 84671-1061 | Powder | Bulk ingredients | April 25, 2025 |
| Pirtobrutinib | 84671-1060 | Powder | Bulk ingredients | April 9, 2025 |
| Trilaciclib hemi-citrate | 84671-1059 | Powder | Bulk ingredients | October 15, 2024 |
| Deferoxamine mesylate | 84671-1016 | Powder | Bulk ingredients | January 24, 2022 |
| Mupirocin calcium | 84671-1046 | Powder | Bulk ingredients | April 30, 2020 |
| Pravastatin sodium | 84671-1022 | Powder | Bulk ingredients | April 30, 2020 |
| Midostaurin amorph | 84671-1058 | Powder | Bulk ingredients | November 14, 2019 |
| Mupirocin | 84671-1017 | Powder | Bulk ingredients | August 21, 2019 |
| Bicalutamide | 84671-1028 | Powder | Bulk ingredients | August 16, 2019 |
| Lovastatin | 84671-1014 | Powder | Bulk ingredients | August 16, 2019 |
| Ondansetron | 84671-1033 | Powder | Bulk ingredients | November 17, 2017 |
| Zaleplon | 84671-1026 | Powder | Bulk ingredients | November 17, 2017 |
| Ondansetron hydrochloride | 84671-1025 | Powder | Bulk ingredients | November 17, 2017 |
| Tobramycin micronized | 84671-1041 | Powder | Bulk ingredients | October 30, 2017 |
| Mycophenolate sodium | 84671-1049 | Powder | Bulk ingredients | January 18, 2017 |
| Simvastatin micronized | 84671-1042 | Powder | Bulk ingredients | April 17, 2013 |
| Tobramycin | 84671-1012 | Powder | Bulk ingredients | April 10, 2013 |
| Lovastatin | 84671-1040 | Powder | Bulk ingredients | January 11, 2013 |
| Imiquimod | 84671-1030 | Powder | Bulk ingredients | November 8, 2010 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.